{
    "id": "correct_subsidiary_00097_2",
    "rank": 37,
    "data": {
        "url": "https://www.pavmed.com/our-company/leadership",
        "read_more_link": "",
        "language": "en",
        "title": "Leadership",
        "top_image": "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f2949992aa1dc3b2c8b7_pavmed-Michael-Gordon_round.webp",
        "meta_img": "",
        "images": [
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6424cbacdaad5e73cabe4eac_icon-search.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/64232d2165a47e13292fcf06_PAVmed-logo-black.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6408e541e0e5f446a73e0f74_logo.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642316c28aada63b9302c805_eyebrow-line.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f1fe8283748306f4ad658_lishan-aklog.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f1fe8283748306f4ad658_lishan-aklog.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f21a9d63476fb08edbda4_dennis-mcgrath.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f21a9d63476fb08edbda4_dennis-mcgrath.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2553caa529332e451566_shaun-oneil.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2553caa529332e451566_shaun-oneil.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f2949992aa1dc3b2c8b7_pavmed-Michael-Gordon_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f2949992aa1dc3b2c8b7_pavmed-Michael-Gordon_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f24e8bfcb431ad4c77fef_brian-deguzman.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f24e8bfcb431ad4c77fef_brian-deguzman.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f28a6f654a9fb83345a3_pavmed-Deepika-Lakhani_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f28a6f654a9fb83345a3_pavmed-Deepika-Lakhani_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f27c988d483a121886fe_pavmed-Suman-Verma_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f27c988d483a121886fe_pavmed-Suman-Verma_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f272988d483a12187982_pavmed-Dr-Victoria-Lee.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f272988d483a12187982_pavmed-Dr-Victoria-Lee.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f1fe8283748306f4ad658_lishan-aklog.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f1fe8283748306f4ad658_lishan-aklog.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2ec7ab89ee1f79cfeb3e_michael-glennon.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2ec7ab89ee1f79cfeb3e_michael-glennon.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2ee9127a6c93b14f9a05_tim-baxter.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2ee9127a6c93b14f9a05_tim-baxter.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2f21cc54e8072191ccef_james-cox.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2f21cc54e8072191ccef_james-cox.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f1afc036e966f109c178_pavmed-Joan-Harvey_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/6488f1afc036e966f109c178_pavmed-Joan-Harvey_round.webp",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2f022a54a82cf4eb899b_ron-sparks.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2f022a54a82cf4eb899b_ron-sparks.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2f3f582920722e7bbd78_debbie-white.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/642f570d57055b2201dd1ca9_modal-close.svg",
            "https://cdn.prod.website-files.com/642335c7d3fad92cdb658254/642f2f3f582920722e7bbd78_debbie-white.png",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6422293de1ccb7379ae07158_icon-linkedin-bios.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/64232d2165a47e13292fcf06_PAVmed-logo-black.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/643f20746e150742b5a70668_icon-tw.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/643f244644c663d65d4110ab_icon-yt.svg",
            "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/643f2446009944e9897f86d4_icon-in.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://cdn.prod.website-files.com/6408cd88ffb481815c3d2c3c/6424cd08654f2a8a4d57e6c6_FAV_32x32.png",
        "meta_site_name": "",
        "canonical_link": "https://www.pavmed.com/our-company/leadership",
        "text": "Dr. Lishan Aklog is Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a diversified, commercial-stage medical technology company which he co-founded, and its majority-owned subsidiary Lucid Diagnostics Inc., a cancer prevention medical diagnostics company (Nasdaq: LUCD). He also serves on the board of the leading medtech industry group, AdvaMed, and as an independent public company director. He previously co-founded a medtech holding company which founded four medical device companies and led one of its portfolio companies which commercialized one of his life-saving inventions, AngioVacÂ®. Dr. Aklog has consulted for leading medtech companies and is an inventor on dozens of patents. The Healthcare Technology Report recognized him as a Top Healthcare Technology CEO in 2021 and 2022. Prior to entering the life sciences industry as an entrepreneur and executive, Dr. Aklog had a distinguished career as an innovator in cardiac surgery, serving on the faculty of leading academic medical centers including Harvard Medical School and Mount Sinai Medical Center, and in professional society leadership positions. He was recognized as an Americaâs Top Doctor for over a decade. He received his undergraduate degree in Physics, magna cum laude, and M.D., cum laude, from Harvard University. He completed his training at Harvard teaching hospitals and leading medical centers in London and Paris.\n\nDennis M. McGrath has served as the Companyâs Executive Vice President and Chief Financial Officer since March 2017.\n\nPreviously, from 2000 to 2017 Mr. McGrath served in several senior level positions of PhotoMedex, Inc. (Nasdaq: PHMD), a global manufacturer and distributor of medical device equipment and services, including from 2011 to 2017 as director, President, and Chief Financial Officer. Prior to PhotoMedexâs reverse merger with Radiancy, Inc in December 2011, he also served as Chief Executive Officer from 2009 to 2011 and served as Vice President of Finance and Chief Financial Officer from 2000 to 2009.\n\nHe received honors as a P.A.C.T. (Philadelphia Alliance for Capital and Technology) finalist for the 2011 Investment Deal of the Year, award winner for the SmartCEO Magazine 2012 CEO of the Year for Turnaround Company, and finalist for the Ernst & Young 2013 Entrepreneur of the Year. He has extensive experience in mergers and acquisitions, both domestically and internationally, and particularly involving public company acquisitions, including Surgical Laser Technologies, Inc, (formerly, Nasdaq: SLTI), ProCyte Corporation (formerly, Nasdaq: PRCY), LCA Vision, Inc. (formerly, Nasdaq: LCAV) and Think New Ideas, Inc. (formerly, Nasdaq: THNK). Prior to PhotoMedex, he served in several senior level positions of AnswerThink Consulting Group, Inc. (then, Nasdaq: ANSR, now, The Hackett Group, Nasdaq: HCKT), a business consulting and technology integration company, including from 1999 to 2000 as Chief Operating Officer of the Internet Practice, the largest division of AnswerThink Consulting Group, Inc., while concurrently during the merger of the companies, serving as the acting Chief Financial Officer of Think New Ideas, Inc. (then, Nasdaq: THNK, now, Nasdaq: HCKT), an interactive marketing services and business solutions company. Mr. McGrath also served from 1996 until 1999 as Chief Financial Officer, Executive Vice President and director of TriSpan, Inc., an internet commerce solutions and technology consulting company, which was acquired by AnswerThink Consulting Group, Inc. in 1999.\n\nDuring his tenure at Arthur Andersen & Co., where he began his career, he became a Certified Public Accountant in 1981 and he holds a B.S., maxima cum laude, in accounting from LaSalle University. In addition to continuing as a director of PhotoMedex, he serves as the audit chair and a director of several medical device companies, including DarioHealth Corp. (Nasdaq: DRIO), Noninvasive Medical Technologies, Inc. and Cagent Vascular, LLC, and as an advisor to the board of an orphan drug company, Palvella Therapeutics, LLC. Formerly from 2007 to 2009, Mr. McGrath served as a director of Embrella Cardiovascular, Inc. (sold to Edwards Lifesciences Corporation, NYSE: EW). He also serves on the Board of Trustees for Manor College and the Board of Visitors for Taylor University.\n\nShaun M. OâNeil has served as the Companyâs Chief Operating Officer since April 2022 and served as Chief Commercial Officer from July 2018 to April 2022.\n\nAs PAVmedâs Chief Operating Officer, he is responsible for the planning and execution of both sales and marketing activities for the U.S., Europe, South America, and Asia. His responsibilities include the development of PAVmedâs strategic partnerships, distribution channels, creation of growth strategies and successful business solutions for branding and positioning of the product lines as well as organize, develop, and grow the sales organization. Shaun works closely with surgeons, clinicians, medical device manufacturers and distributors, technology business managers, as well as research and development partners around the globe.\n\nWith a solid track record of sales and marketing leadership, and product and business development expertise in both startup and established companies, including a particularly strong track record in growing sales and increasing market share for innovative medical devices. Since 2011, Mr. OâNeil has held various sales and marketing leadership positions with AngioDynamics (Nasdaq: ANGO), a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. Most recently he served as regional sales manager for its peripheral vascular division, where he oversaw multiple territory managers and clinical specialists. He was responsible for multiple product launches and was a perennial recipient of sales and performance awards. Prior to AngioDynamics, he served in various sales, marketing, and engineering roles at Aycan Medical Systems, a privately-held medical imaging company.\n\nMr. OâNeil received a B.S. in Business Administration with a focus in management information systems from Alfred University and an M.B.A. from the Rochester Institute of Technology.\n\nMichael A. Gordon has served as the Companyâs General Counsel and Secretary since May 2022. Mr. Gordon has also served as the General Counsel and Secretary of Lucid, the Companyâs majority owned subsidiary, since May 2022. Previously, from October 2006 to May 2022, he was a member of the corporate department of the law firm Friedman Kaplan Seiler & Adelman LLP, where he was a partner from January 2013 through May 2022, and a member of the firmâs management committee from January 2019 through May 2022. While at Friedman Kaplan, Mr. Gordon represented PAVmed and Lucid in a range of M&A, financing and other corporate and commercial transactions, and also advised the companies and their boards on corporate governance matters. Prior to joining Friedman Kaplan, Mr. Gordon was a corporate associate with the law firm Cravath Swaine & Moore LLP. Mr. Gordon received his J.D. from Fordham University School of Law, where he graduated magna cum laude in 2004, and his A.B. in Economics from Dartmouth College, where he graduated cum laude in 1996.\n\nDr. deGuzman has served as PAVmedâs Chief Medical Officer since October 2014 and served as a Director from October 2014 to January 2015. Dr. deGuzman has previously served as a co-founding Partner of Pavilion Holdings Group (âPHGâ), a medical device holding company, and Pavilion Medical Innovations (âPMIâ), a venture-backed medical device incubator, since their respective inceptions in 2007 and 2009.\n\nDr. deGuzman has been President and Chief Executive Officer of Kaleidoscope Medical since its founding in February 2013 and has also served as a Senior Advisor to PMI portfolio companies Saphena Medical since February 2013 and Cruzar Medsystems since July 2013. Dr. deGuzman served as Chief Medical Officer of Vortex Medical from inception until its sale to AngioDynamics, for whom he continues to serve as a consultant. Dr. deGuzman has also been a consultant to Biomet and Atricure since 2007, and on the Revascularization Scientific Advisory Board of Maquet Cardiovascular (formerly Boston Scientific and Guidant Cardiac Surgery) since 2006.\n\nDuring his surgical career, Dr. deGuzman also served as a consultant to various medical device companies, including Edward Lifesciences. Prior to moving into the medical device industry full-time in 2012, Dr. deGuzman was Assistant Professor of Surgery, Associate Chief of Cardiovascular Surgery, and Surgical Director of the Atrial Fibrillation Clinic at St. Josephâs Hospital and Medical Centerâs Heart and Lung Institute from 2006 to 2012. From 2002 to 2006, Dr. deGuzman was Assistant Professor of Surgery at Tufts University School of Medicine and an attending cardiac surgeon at the Lahey Clinic Medical Center in Massachusetts. From 2001 to 2002, Dr. deGuzman was a Clinical Associate of Cardiac Surgery at the Cleveland Clinic.\n\nDr. deGuzman received his general surgical training at the University of Connecticut/Hartford Hospital, was a Research Fellow at Harvard Medical Schoolâs Cardiac Surgery Research Laboratory, and received his cardiothoracic surgical training at Brigham and Womenâs Hospital and Boston Childrenâs Hospital. Dr. deGuzman was recognized as a Top Doctor in Cardiovascular Surgery by Boston Magazine. Dr. deGuzman received his B.S. in Biology from Boston College and his M.D. from Georgetown University School of Medicine.\n\nDr. Deepika Lakhani is an internationally recognized regulatory professional with over 15 years of experience with the Food and Drug Administration (FDA) and industry. Her interest in regulatory affairs started during her Doctorate studies at Virginia Commonwealth University where she collaborated with the FDA on an academic research project that fostered her interest in understanding regulations impacting the pharmaceutical and medical device industry. Right out of graduate school she started working as a reviewer at the Center for Drugs Evaluation and Research at the FDA where she spent >5 years in different capacities followed by >5 years at Center for Devices and Radiological Health. During her tenure at the FDA, she has reviewed, led cross-discipline teams, and contributed to policies impacting drugs, biologics, medical devices, tobacco products and combination products and served as FDAâs liaison to ISO committees. More recently in the healthcare industry she has lead efforts for global regulatory approvals of drugs, medical devices, combination products and emerging technologies and demonstrated expertise in tactically leading global regulatory teams using her sharp acumen for regulatory strategy and expertise in policy to maximize regulatory success. Â Through her experience working at the FDA and then in the industry at AstraZeneca and while consulting for Johnson and Johnson, she has gained in-depth understanding of global regulatory pathways from a vast portfolio of drugs, medical devices, and combination products. Most importantly she has a mindset that bringing products to market, especially those that are innovative, can benefit from a creative regulatory process and strives to provide âregulatory enablementâ using both standard and out-of-the-box thinking.\n\nDeepika received her bachelorâs degree in pharmacy in Delhi, India and her PhD in Pharmaceutics from Virginia Commonwealth University. Â She has multiple peer-reviewed publications, received many awards for excellence and leadership while at the FDA and in the industry.\n\nDr. Lee has served as the Companyâs Chief Medical Officer since April 2023 and served as the Vice President of Medical Affairs from August 2022 to March 2023.\n\nPrior to joining PAVmed, from November 2020 to August 2022 Dr. Lee was first a Director, and later the Senior Director of Clinical Affairs at CytoSorbents Inc., a publicly traded medical device company specializing in blood purification technology. Preceding her move into the medical device industry, from 2019-2020 Dr. Lee was an Associate Medical Director at Syntactx (now part of NAMSA), a medical device focused CRO with a strong reputation for expert clinical trial support in the cardiovascular disease space. Dr. Lee has also served as a physician consultant at McKinsey and Company from 2017-2018, where areas of interest included medical policy, resource utilization, and optimizing efficiencies in healthcare.\n\nDr. Lee has experience in both pre-market and post-market clinical trials; trial designs have included multicenter, randomized control trials; multi-center, case-control trials; prospective, single-arm, open-label trials; multi-center registries; retrospective cohort studies; and Â virtual patient trials. Research responsibilities have included trial design, contracting and selection of CROs and AROs, protocol development, safety oversight and medical monitoring, organization of Steering Committees, collaboration with KOLs, and general oversight of clinical research operations. She has been a frequent collaborator on regulatory submissions to the FDA and European regulatory authorities, including successful requests for breakthrough device designation.\n\nDr. Lee graduated from the NYU Grossman School of medicine in 2011 and began her surgical training in general surgery at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. Shortly thereafter, she returned to NYU Langone Medical Center when offered a position as the inaugural member of their Integrated Vascular Surgery Residency program, where she ultimately completed her training and obtained her Board Certification in Vascular Surgery. Dr. Lee received her B.S. in Cellular, Molecular, and Developmental Biology at the University of Washington, Seattle.\n\nâ\n\nDr. Lishan Aklog is Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a diversified, commercial-stage medical technology company which he co-founded, and its majority-owned subsidiary Lucid Diagnostics Inc., a cancer prevention medical diagnostics company (Nasdaq: LUCD). He also serves on the board of the leading medtech industry group, AdvaMed, and as an independent public company director. He previously co-founded a medtech holding company which founded four medical device companies and led one of its portfolio companies which commercialized one of his life-saving inventions, AngioVacÂ®. Dr. Aklog has consulted for leading medtech companies and is an inventor on dozens of patents. The Healthcare Technology Report recognized him as a Top Healthcare Technology CEO in 2021 and 2022. Prior to entering the life sciences industry as an entrepreneur and executive, Dr. Aklog had a distinguished career as an innovator in cardiac surgery, serving on the faculty of leading academic medical centers including Harvard Medical School and Mount Sinai Medical Center, and in professional society leadership positions. He was recognized as an Americaâs Top Doctor for over a decade. He received his undergraduate degree in Physics, magna cum laude, and M.D., cum laude, from Harvard University. He completed his training at Harvard teaching hospitals and leading medical centers in London and Paris.\n\nMichael J. Glennon has served as PAVmedâs Vice Chairman and a Director since October 2014. Mr. Glennon has served as a co-founding Partner of both Pavilion Holdings Group (âPHGâ), a medical device holding company, and Pavilion Medical Innovations (âPMIâ), a venture-backed medical device incubator, since their respective inceptions in 2007 and 2009 and also serves as Chairman and Chief Executive Officer of PMI.\n\nMr. Glennon has served as President, Chief Executive Officer and a director of Saphena Medical since February 2013 and Cruzar Medsystems since July 2013 and as a director of Kaleidoscope Medical since January 2013. Mr. Glennon was the President and Chief Executive Officer of Vortex Medical from its inception in 2008 until its acquisition in October 2012 by AngioDynamics.\n\nFrom 2005 to 2007, Mr. Glennon was Senior Vice President â Sales and Marketing for Accellent Inc., a market-leading provider of outsourced precision manufacturing and engineering services to the medical device industry. Accellent was a portfolio company of DLJ Merchant Banking Partners and was acquired in 2005 by KKR and Bain Capital. From 2004 to 2005, Mr. Glennon was a Cardiac Rhythm Management District Manager at Medtronic. From 1996 to 2004, Mr. Glennon was a Sales Manager at Guidant including seven years at Guidant Cardiac Surgery (now, Maquet Cardiovascular). He was instrumental in the launch and rapid growth of VasoView, the first endoscopic vessel harvesting technology, which became the standard of care in coronary bypass surgery. From 1993 to 1995, Mr. Glennon worked for Origin Medsystems which was acquired by Eli Lilly and subsequently spun out as part of Guidant. Previously, Mr. Glennon was with Stryker Endoscopy and Storz Instrument Company.\n\nMr. Glennon received his B.S. in Business Administration from the University of New Hampshire.\n\nMr. Baxter spent thirteen years in senior executive roles during a rapid-growth period at Samsung Electronics Co., LTD, the worldâs second-largest technology company. He was its first non-Korean-born C-suite executive and rose to become President and Chief Executive Officer, North America â responsible for 6,000 employees and $30 billion in revenue. He was lauded for capitalizing on emerging trends, scaling businesses, building teams, strengthening brand loyalty, deploying emerging technology platforms, and successfully managing unanticipated challenges. Before retiring, he developed the companyâs long-term strategic plan for capitalizing on emerging technologies, including 5G, artificial intelligence, cloud-based computing, and Internet of Things (IOT).\n\nPrior to Samsung, Mr. Baxter spent ten years in various senior marketing and general manager roles at Sony Corporation, where he helped navigate the analog to digital shift in its crown jewel television business unit and successfully led all Hollywood studio negotiations in the Blu-Ray packaged media format war win. Earlier in his career, he served in senior sales and marketing roles at AT&T Inc. and Lucent Technologies Inc., where he was instrumental in launching go-to-market plans, lifecycle management as well as building and globalizing its brand for a $1 billion business unit.\n\nMr. Baxter has served as an industry-wide leader, including as a member of the Executive Board of CTIA, a leading wireless communication industry trade association, and as a Director of the Consumer Electronics Association (CEA), the leading consumer technology association. He currently serves as a Senior Advisor at McKinsey & Co, Operating Partner at Centre Partners Management LLC, a leading middle market private equity firm, Executive Chair of private-equity backed Tastemakers Holdings LLC, a leading developer and marketer of specialty gaming products, Lead Outside Director of First Orion Corp., a technology software company, Advisory Board member of Almo Distribution, the largest independent U.S. distributor of appliances, consumer electronics, professional audio/video equipment, furniture and housewares, and as an advisor to Raxium Inc., a start-up company developing next generation display technology. Mr. Baxter received his undergraduate degree in Marketing and Finance at Roger Williams University and currently serves as Chairman of its Board of Trustees.\n\nâ\n\nDr. Cox has served as a Director of PAVmed since January 2015. Dr. Cox is a cardiac surgeon, scientific investigator and medical device entrepreneur who pioneered the field of surgical intervention for cardiac arrhythmias, including the eponymous Cox-Maze procedure for the treatment of atrial fibrillation.\n\nFrom 1983 to 1997, Dr. Cox served as Professor of Surgery and Chief of the Division of Cardiothoracic Surgery at Washington University School of Medicine and Cardiothoracic Surgeon-in-Chief at Barnes Hospital in St. Louis. During this tenure, he became the first Evarts A. Graham Professor of Surgery and Vice-Chair of the Department of Surgery. He is currently the Evarts A. Graham Professor of Surgery Emeritus. Dr. Cox was also previously Professor and Chairman of the Department of Thoracic and Cardiovascular Surgery at Georgetown University Medical Center and Associate Professor of Surgery at Duke University Medical Center.\n\nDr. Cox has had a distinguished and highly productive academic career. He has published 360 peer-reviewed scientific articles and has served on the editorial boards of numerous journals, including Circulation, the Journal of Thoracic and Cardiovascular Surgery, the Annals of Surgery, and the Journal of Electrophysiology. His laboratory has received continuous NIH funding for its research on the surgical treatment of cardiac arrhythmias. Dr. Cox has served in leadership positions at numerous professional organizations. He was the 81st President of the American Association of Thoracic Surgery and a director of the American Board of Thoracic Surgery. He has been invited to lecture and perform surgery as a visiting professor at dozens of institutions around the world. He has received numerous awards and honors for his clinical and scientific work, most notably as one of 30 âPioneers in Thoracic and Cardiovascular Surgeryâ at a ceremony commemorating the 50th anniversary of the specialty. Dr. Cox holds 15 issued patents. He has been instrumental in the founding of six medical device companies, including Epicor Medical, which was acquired by St. Jude Medical in 2004 for $200 million, and 3F Therapeutics, which was acquired in 2006 by ATS Medical for $40 million. At such time, he became Medical Director of ATS Medical, which was subsequently acquired by Medtronic in 2010 for $370 million.\n\nDr. Cox has served on numerous scientific advisory boards, including Medtronic, St. Jude Medical, Atricure and CorMatrix. He is also the Founder and Chairman of the Board of Directors of the World Heart Foundation, a not-for-profit organization devoted to improving access to cardiac surgery, which is active in over 75 developing countries around the world. Dr. Cox received his general and cardiothoracic surgical training at Duke University School of Medicine, during which time he spent two years in the U.S. Army Medical Corps.\n\nDr. Cox received his M.D. from the University of Tennessee, where he received the Alpha Omega Alpha Distinguished Graduate Award as the outstanding student in his class.\n\nJoan B. Harvey has served as a director since February 2022. Ms. Harvey has extensive corporate leadership in the health care space, with more than two decades of health care experience serving in a variety of leadership roles dedicated to improving whole person health and advocating for patients. She is the president of Care Solutions for Evernorth, Cigna Corporationâs (NYSE: CI) health services business. In this role, she oversees Evernorthâs medical, behavioral, and pharmacy clinical programs to meet the diverse needs of health plans, employers, government organizationsâand the people they serve. Prior to joining Evernorth, Ms. Harvey served in senior leadership roles at Cigna, Medco Health Solutions Inc., WellPoint 360 Health. a subsidiary of Anthem, Inc., American Imaging Management, and Oxford Health Plans, LLC, a subsidiary of UnitedHealth Group. She is a founding member of the Disease Management Association of America, and author of âAsthma Disease Management in the 21st Centuryâ for the Managed Care Handbook: Best Practices in Medical Management. Ms. Harvey holds a Master of Business Administration from the American Graduate School of International Management and a Bachelorâs degree in International Relations from Bates College. The Company believes Ms. Harvey is well-qualified to serve on the Board due to her significant experience in executive leadership roles in the healthcare industry and her demonstrated commitment to patient care, as well as her extensive business relationships and contacts.\n\nRonald M. Sparks has served as a Director of PAVmed since January 2015. Mr. Sparks has more than 37 years of executive experience in the medical device industry and has launched over 50 products across a wide spectrum of specialties, including orthopedics, endoscopy, wound management, cardiology, interventional radiology, diagnostic imaging, ophthalmology and otology. From 2007 to October 2013, he served as a Healthcare Industry Executive at Avista Capital Partners, a private equity firm. Mr. Sparks served as Chairman and Chief Executive Officer of Navilyst Medical Inc., which was formed by Avista Capital to acquire the fluid management and venous access business units of Boston Scientific, from its inception in 2008 until its acquisition in May 2012 by AngioDynamics for $372.0 million.\n\nFrom 2003 to 2007, he served as President, Chief Executive Officer and a director of Accellent, a market-leading provider of outsourced precision manufacturing and engineering services to the medical device industry. Accellent was a portfolio company of DLJ Merchant Banking Partners and was acquired in 2005 by KKR and Bain Capital. During his tenure at Accellent, he was recognized as the Credit Suisse/DLJ Merchant Bank 2005 CEO of The Year. From 1986 to 2003, he served in various leadership roles at Smith & Nephew as a member of the Group Executive Committee, President of the Endoscopy Division, President of the Wound Management Division and Vice President of Finance.\n\nEarlier in his career, he served in various finance roles at Richards Medical, Dyonics and Union Carbide Imaging. Mr. Sparks is a fellow of the American Sports Medicine Institute, a Trustee of the Arthroscopy Association of North America Education Foundation and Honorary Lifetime Member of the International Society of Arthroscopy, Knee Surgery and Orthopedic Sports Medicine. He has previously served on numerous boards and industry councils, including AdvaMed, the National Subacute Care Association, the American College of Foot and Ankle Surgeons, the American Council of Orthopedic Surgeons and the Society of Interventional Radiology.\n\nMr. Sparks received his B.S. in Finance and Accounting from the University of Massachusetts and attended the INSEAD Advanced Management Program at the European Institute of Business Administration in Fontainebleau, France.\n\nMs. White currently serves on the board of directors of Howden Joinery Group PLC (LSE: HWDN), a UK-headquartered FTSE250 multinational building trade supplier with 10,000 employees and over $2 billion in revenue and as a trustee of Wellbeing of Women, a UK charity which invests in medical research and development of specialist clinicians in womenâs health. Ms. White recently served as a strategic consultant to Oxford Nanopore Technologies Ltd., a UK biotechnology company that develops and commercializes DNA/RNA sequencing technologies, and its emerging Oxford Nanopore Diagnostics business unit.\n\nEarly in the COVID-19 pandemic, Ms. White worked with the UK government to help establish COVID-19 testing facilities across the nation.\n\nMs. White previously served as Group CEO of Interserve Group (LSE: IRV), a UK-headquartered multinational group of support services and construction companies with 75,000 employees and over $4 billion in revenue, during a challenging period which required her to implement complex strategic financing and operational programs prior to its restructuring and sale to its creditors.\n\nPrior to Interserve, Ms. White spent 13 years in senior executive roles at Sodexo SA (EuroNext: SW), a Paris-headquartered multinational diversified services company with 440,000 employees and over $20 billion in revenue, including as Chief Executive Officer of Sodexo UK & Ireland, Chief Financial Officer of Sodexo North America, an $8 billion subsidiary, and finally as Executive Board member and Global Chief Executive Officer of Healthcare and Government, two global businesses with a combined 100,000 employees and over $7 billion in revenue. While at Sodexo, she served on its global body that promoted the development of women across the company and was inducted into the industryâs Women 1st Top 100 Club, which highlights the female role models and leaders who have achieved success at the highest levels.\n\nPrior to Sodexo, Ms. White served for 3 years as a Director at PWC Consulting, advising a range of industries, including pharmaceuticals, on integration, financial performance improvement and post-merger integration, and for 13 years in various financial and strategic roles at AstraZeneca (LSE: AZN), a UK-headquartered multinational pharmaceutical and biotechnology company. She began her career as a senior tax advisor at Arthur Andersen & Co. Ms. White received her masterâs degree in Economics from Cambridge University, Cambridge UK."
    }
}